Suppr超能文献

血管舒张性休克成人患者的血压目标——一项个体患者数据荟萃分析

Blood Pressure Targets for Adults with Vasodilatory Shock - An Individual Patient Data Meta-Analysis.

作者信息

Angriman Federico, Momenzade Neda, Adhikari Neill K J, Mouncey Paul R, Asfar Pierre, Yarnell Christopher J, Ong Sean Wei Xiang, Pinto Ruxandra, Doidge James C, Shankar-Hari Manu, Harhay Michael O, Masse Marie-Hélène, Harrison David A, Rowan Kathryn M, Li Fan, Carter Francis, Camirand-Lemyre Felix, Lamontagne François

机构信息

Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto.

Interdepartmental Division of Critical Care Medicine, University of Toronto.

出版信息

NEJM Evid. 2025 Jan;4(1):EVIDoa2400359. doi: 10.1056/EVIDoa2400359. Epub 2024 Nov 18.

Abstract

BACKGROUND

We sought to estimate whether a lower mean arterial blood pressure target, compared with a higher mean arterial blood pressure target, reduced 90-day all-cause mortality among critically ill adult patients with vasodilatory shock.

METHODS

We conducted an individual patient data meta-analysis of randomized controlled trials that evaluated the effect of distinct thresholds of mean arterial blood pressure to guide vasopressor support among critically ill adults identified in a systematic literature search. The main exposure was a lower mean arterial pressure target compared with a higher mean arterial pressure target (including usual care). The primary outcome was 90-day all-cause mortality. We used a Bayesian random effects log-binomial model to estimate risk ratios with 95% credible intervals (CrIs).

RESULTS

Between 2010 and 2019, 3352 patients were randomly assigned in three trials (SEPSISPAM, OVATION pilot trial, and 65-Trial) across 103 hospitals from the United Kingdom, France, and Canada. When compared with a higher mean arterial blood pressure target or usual care, the risk ratio for 90-day all-cause mortality associated with a lower blood pressure target was 0.93 (95% CrI, 0.76 to 1.07; low certainty, posterior probability of benefit 87%). Results were consistent across multiple secondary and sensitivity analyses, including adjustment for prognostically important baseline covariates and alternative modeling techniques. Multiple approaches to evaluate the heterogeneity of treatment effect did not identify any subgroups that may potentially benefit from higher mean arterial blood pressure targets.

CONCLUSIONS

Targeting a lower mean arterial blood pressure for vasopressor therapy in critically ill patients with vasodilatory shock possibly reduced 90-day all-cause mortality. However, the certainty of evidence is low, and this analysis does not exclude the possibility that lower targets may cause harm overall.

摘要

背景

我们试图评估与较高的平均动脉血压目标相比,较低的平均动脉血压目标是否能降低成人重症血管舒张性休克患者90天全因死亡率。

方法

我们对随机对照试验进行了个体患者数据荟萃分析,这些试验评估了不同平均动脉血压阈值对在系统文献检索中确定的重症成人患者血管升压药支持的指导作用。主要暴露因素是与较高平均动脉血压目标(包括常规治疗)相比,较低的平均动脉血压目标。主要结局是90天全因死亡率。我们使用贝叶斯随机效应对数二项模型来估计风险比及95%可信区间(CrIs)。

结果

2010年至2019年期间,来自英国、法国和加拿大的103家医院的三项试验(SEPSISPAM、OVATION先导试验和65试验)中,3352例患者被随机分组。与较高的平均动脉血压目标或常规治疗相比,较低血压目标相关的90天全因死亡率风险比为0.93(95% CrI,0.76至1.07;低确定性,获益的后验概率为87%)。在包括对预后重要的基线协变量进行调整和替代建模技术在内的多个次要和敏感性分析中,结果是一致的。评估治疗效果异质性的多种方法未发现任何可能从较高平均动脉血压目标中获益的亚组。

结论

在重症血管舒张性休克患者中,将较低的平均动脉血压作为血管升压治疗目标可能会降低90天全因死亡率。然而,证据的确定性较低,并且该分析不排除较低目标可能总体上造成伤害的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验